Lycksele municipality in Sweden, which already used Evondos in homecare, faced a unique and acute challenge within its nursing home environment: A high proportion of medication deviations, often caused by staff shortages.
This study demonstrates how moving beyond the unit price of a basic dispenser and investing in a specialised feature (Evondos' full-service, purpose-built assisted mode) was a strategic decision to mitigate risk, restore compliance, and introduce unprecedented flexibility into their delegation-constrained staff planning. This investment ensures staff have the most reliable partner they can depend on to handle this complex environment.
Lycksele's high medication deviation rate stemmed from a system where a single delegated staff member was responsible for medicines for all residents on the ward. This centralisation of risk created dual operational problems:
The municipality needed a high-trust partner and a compliant solution to improve quality and safety and reduce these deviations, specifically by increasing flexibility in planning.
Lycksele’s objective was to decouple medication administration from strict delegation requirements using a high-trust, technical control layer that provides real value, safety and quality care. This investment was intended to:
Lycksele chose Evondos for its ability to provide a solution tailored specifically to the complexity of the nursing home environment — the Evondos assisted mode. This represents an investment in a full platform and partnership, not just a device.
Dedicated customer success partnership: The investment is backed by dedicated Customer Success Managers (CSMs), who are often highly trained with a care background. The CSMs guide the nursing home through the specific implementation of Assisted Mode, providing training, coaching on best practices and ensuring staff can adopt the new, safer ways of working. This vital, ongoing support is a key value add and ensures the successful integration of health tech.
This feature transformed the device from an independent client tool into a controlled workflow device for the staff:
This combination of premium hardware, innovative software, and expert human support proves that Lycksele invested in the best-in-class partner with an unmatched track record of reliability and compliance.
The assisted mode allowed Lycksele to strategically increase flexibility in planning. By using the robot to manage the actual dispensing mechanism, responsibility could be safely shared among staff. This meant people who were not approved to delegate medication could still, with the robot's help, administer it, ensuring that more staff were able to do more.
The strategic investment in Evondos assisted mode delivered immediate operational and safety value.
The primary objective of safer medication management and deviation reduction was directly addressed.
The investment directly addressed the challenges of staff rigidity and reliance on delegated staff.
While specific monetary data is not public, the savings are realised through the avoidance of costs associated with high deviation rates and staff churn.
For Lycksele, the investment in Evondos was a crucial strategic move: They purchased guaranteed medication safety, restored flexibility to staff scheduling and mitigated the costly operational risks associated with delegation, proving the long-term value of a compliant, purpose-built partner.
That decision now empowers their care organization to use their resources wisely, allowing them to focus on the care tasks that cannot be automatized, leading to happier staff and better outcomes for residents.
Ready to see the Evondos impact for yourself? Speak to us today to find out how we can provide the long-term value and strategic partnership needed to future-proof your healthcare service.